![Ilse Roodink](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Ilse Roodink formerly worked at ImmunoPrecise Antibodies (Europe) BV, as Scientific Director and MindWalk Holdings Corp., as Chief Scientific Officer from 2021 to 2025.
Dr. Roodink received her undergraduate degree, graduate degree, and doctorate degree from Radboud University Nijmegen.
Anciens postes connus de Ilse Roodink
| Sociétés | Poste | Fin |
|---|---|---|
| MINDWALK HOLDINGS CORP. | Directeur Technique/Scientifique/R&D | 06/08/2025 |
Immunoprecise Antibodies (Europe) BV
 Immunoprecise Antibodies (Europe) BV Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that specializes in antibiotics | Directeur Technique/Scientifique/R&D | - |
Formation de Ilse Roodink
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
19
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Radboud University Nijmegen
 Radboud University Nijmegen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ImmunoPrecise Antibodies Ltd.
 ImmunoPrecise Antibodies Ltd. BiotechnologyHealth Technology Operates as AI-driven biotherapeutic research and technology firm that develops & discovers antibodies | Health Technology |
Immunoprecise Antibodies (Europe) BV
Immunoprecise Antibodies (Europe) BV Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that specializes in antibiotics | Health Technology |
